NutriLeads B.V., a Dutch Nutrition & Health startup, announces the positive outcome of a proof of concept study in humans demonstrating that its lead ingredient IMPP-1 is safe, well tolerated and supports immune function in humans.


This clinical study has been conducted by a&r’s clinical R&D department at a&r’s study center in Berlin.

NutriLeads develops nutritional ingredients for application in health-promoting food products. Their lead ingredient Immuno Modulatory Plant Polysaccharide-1 (IMPP-1) can be sustainably sourced from food crops. They are developing this patented ingredient for different food applications including dietary supplements, medical food and functional food to reach various target populations.

NutriLeads and 4 European partners – incl. a&r – have been awarded a € 2 million Eurostars project called NIMF. The consortium will develop NutriLeads’ proprietary ingredient Immune Modulatory Plant Polysaccharide-1 (IMPP-1) into a new ingredient for medical food products to fight impaired immune functioning as a result of malnutrition.

Download here the press release:

For more information: